Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery

  1. Rubio-Herrera, M.A.
  2. Mera-Carreiro, S.
  3. Sánchez-Pernaute, A.
  4. Ramos-Levi, A.M.
Journal:
Biomedicines

ISSN: 2227-9059

Year of publication: 2023

Volume: 11

Issue: 10

Type: Article

DOI: 10.3390/BIOMEDICINES11102785 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus